Highlight of 2023: Unlocking the therapeutic potential of natural killer cells-advances in adaptive functions, cellular engineering and immunotherapy.

Lam, Pui Yeng; Souza-Fonseca-Guimaraes, Fernando

Lam, Pui Yeng; Souza-Fonseca-Guimaraes, Fernando.

Lam PY; Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.
Souza-Fonseca-Guimaraes F; Frazer Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, QLD, Australia.

Immunol Cell Biol ; 102(6): 444-447, 2024 Jul.

Article en En | MEDLINE | ID: mdl-38693888

ABSTRACT

ABSTRACT

Natural killer (NK) cells possess potent cytotoxicity against infected and cancerous cells and hold promise in the development of new immunotherapies. This article for the Highlights of 2023 Series focuses on current advances in NK cell biology in cancerous and infectious settings and highlights opportunities for therapeutic interventions, including engineered NK cell therapies and advancements in feeder cell technologies.

Asunto(s)

Ingeniería Celular; Inmunoterapia; Células Asesinas Naturales; Neoplasias; Animales; Humanos; Citotoxicidad Inmunológica; Inmunoterapia/métodos; Inmunoterapia Adoptiva/métodos; Células Asesinas Naturales/inmunología; Neoplasias/terapia; Neoplasias/inmunología

Palabras clave

Adaptive functions; NK cells; cellular engineering; immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Células Asesinas Naturales / Ingeniería Celular / Inmunoterapia / Neoplasias Límite: Animals / Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google